To prepare the clinical trial agreement, you can use models written by a collaboration of parties gathered within the Dutch Clinical Research Foundation (DCRF). Two models are available: one for industry-funded research and the other for research initiated by researchers. Participants participated in Top Clinical Training Hospitals (STZ), the Netherlands Federation of University Medical Centers (NFU), the Association of Innovative Medicines, the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital (NKI/AvL) and the Association of Contract Research Organizations in the Netherlands (ACRON). Sub-price/subcontracting: agreement granted to the university under a main contract, agreement or grant. MICRA was developed by a working group led by the NIHR Office for Clinical Research Infrastructure (NOCRI) and the Medical Research Council. Representatives from industry, universities, the NHS and the Intellectual Property Office worked with legal opinions to develop a model agreement that could support all collaborative research scenarios. Organizations participating in the working group agreed on a statement of support in which they encouraged their use to streamline the collaborative research allocation process. Equipment agreement: an agreement reached between the university and a staff member during the pre-proposal funding phase. This agreement allows the parties to express their willingness to cooperate in the allocation of a financing opportunity, to review future subcontracting projects and to ensure the protection of confidential information exchanged. These agreements are often required by companies that wish to ensure the confidential treatment of all proprietary information they have disclosed while cooperating with the proposal.
In reviewing the Clinical Trials Agreement, an accredited medical research ethics committee (MREC) and the CCMO will follow the CCMO Clinical Trial Agreement Evaluation Directive. The directive applies to research within the scope of the WMO and where there is a written agreement between the parties to fund, organize and conduct the research. Confidentiality Agreement (CDA or NDA): an agreement that allows faculties and collaborators at the University of Washington to exchange confidential information with outside third parties who are required to protect and respect the confidentiality of information. In general, CDAs are concluded for the purpose of studying possible research cooperation or a licensing agreement. The Intellectual Property Office (IPO) is the official authority of the UK government for intellectual property rights (IP), including patents, designs, trademarks and copyrights.